Big news could cause these biotech stocks to go up or down. Biotech's biggest stories this year include trial data and Food and Drug Administration decisions for therapies targeting indications with a massive need for new treatment options, including blood disorders, genetic diseases, and Alzheimer's disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,